Aisaka K

No ORCID on file · 5 papers in corpus · active 1997-2017

Study types

  • article 4

Condition tags

  • endometriosis 4
  • infertility 1
2017
Phase III trial comparing the efficacy and safety of recombinant- or urine-derived human chorionic gonadotropin for ovulation triggering in Japanese women diagnosed with anovulation or oligo-ovulation and undergoing ovulation induction with follitropin-alfa.
Reproductive medicine and biology ·doi:10.1002/rmb2.12008

AimOutside of Japan, recombinant-human chorionic gonadotropin (r-hCG) is widely used for the induction of final follicular maturation and early luteinization in women undergoing ovulation induction; whereas in Japan, urine-derived hCG (u-hC…

article 2009
[Effectiveness of bisphosphonate administration during Gn-RH agonist therapy for endometriosis].
Nihon rinsho. Japanese journal of clinical medicine

Gn-RH agonist therapy is widely used for treatment of endometriosis. However, it is well known that there are some side effects due to too much suppress of plasma sex steroid hormone levels. The decrease of the BMD (bone mineral density) is…

article 2007
[Effectiveness of bisphosphonate administration for prevention of osteopenia during Gn-RH agonist therapy of endometriosis].
Nihon rinsho. Japanese journal of clinical medicine
article 2001
[Add back therapy for patients with endometriosis].
Nihon rinsho. Japanese journal of clinical medicine
article 1997
[Female sterility].
Nihon rinsho. Japanese journal of clinical medicine

Recent progress in female sterility of Japanese women is reported in this study. The causes of sterility in the female side, the most popular sterile factor is a tubal factor due to the increase of the endometriosis and pelvic inflammatory …